BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28548306)

  • 61. Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.
    Sun F; Sun P; Yang X; Hu L; Gao J; Tian T
    Aging (Albany NY); 2021 Sep; 13(18):22528-22543. PubMed ID: 34555811
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis.
    Liu J; Gao L; Zhang H; Wang D; Wang M; Zhu J; Pang C; Wang C
    J Biol Chem; 2013 Oct; 288(41):29965-73. PubMed ID: 23983127
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
    Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma.
    Chua HH; Tsuei DJ; Lee PH; Jeng YM; Lu J; Wu JF; Su DS; Chen YH; Chien CS; Kao PC; Lee CN; Hu RH; Ni YH; Chang MH
    Hepatology; 2015 Nov; 62(5):1480-96. PubMed ID: 26185016
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3
    Liao M; Du H; Wang B; Huang J; Huang D; Tong G
    Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hydroalcoholic root extracts of Houttuynia cordata (Thunb.) standardized by UPLC-Q-TOF-MS/MS promotes apoptosis in human hepatocarcinoma cell HepG2 via GSK-3β/β-catenin/PDL-1 axis.
    Sarkar S; Kar A; Shaw P; DasGupta B; Keithellakpam OS; Mukherjee PK; Bhardwaj PK; Sharma N; Haldar PK; Sinha S
    Fitoterapia; 2023 Dec; 171():105684. PubMed ID: 37751799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway.
    Yang L; Tan W; Wei Y; Xie Z; Li W; Ma X; Wang Q; Li H; Zhang Z; Shang C; Chen Y
    Cell Death Dis; 2022 May; 13(5):464. PubMed ID: 35581180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
    Li N; Yang C; Xia J; Wang W; Xiong W
    Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
    J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
    Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
    Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
    Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
    Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
    [No Abstract]   [Full Text] [Related]  

  • 77. SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3β/β-catenin signaling in HCC cells.
    Liu J; Zhang G; Lv Y; Zhang X; Ying C; Yang S; Kong X; Yu Y
    Tumour Biol; 2017 Jun; 39(6):1010428317700408. PubMed ID: 28639896
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells
    Wang J; Cao C; Zeng Q; Dong Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):679-684. PubMed ID: 31270046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
    Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY
    PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.